This is a type of skin growth called a tumor. It's usually found in babies and young children, often in the jaw area. It's called 'melanotic' because it's very dark in color, like a mole. It's a type of neuroectodermal tumor, which is a group of rare tumors that start in the early nervous system.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
A melanotic neuroectodermal tumor, usually called melanotic neuroectodermal tumor of infancy (MNTI), is a rare tumor that almost always appears in babies during their first year of life. It most often grows in the upper jaw (the maxilla), where it shows up as a firm, painless swelling of the front gum that can look bluish or black because the tumor contains the dark pigment melanin. It can also arise in the skull, the lower jaw, around the eye or, rarely, elsewhere in the body. Most of these tumors are benign, meaning they are not cancer and rarely spread to distant parts of the body. They still matter because they grow quickly and push into nearby bone, teeth and tissue. Left alone, a tumor can distort the face, displace developing teeth and interfere with feeding. A small minority behave like a cancer and spread to lymph nodes or beyond. Older names for the same tumor include melanotic progonoma and retinal anlage tumor.
No one knows exactly why MNTI develops. The tumor is thought to come from neural crest cells, a group of cells in the developing embryo that go on to form parts of the face, nerves and pigment cells. That is why it appears so early in life, sometimes even at birth. There are no known lifestyle, pregnancy or environmental causes, and nothing a parent did or did not do is known to bring it on. It is slightly more common in boys. Because the tumor is so rare, its causes have been studied mainly through individual case reports rather than large studies.
A fast-growing, dark swelling of an infant's gum is a strong clue, but it can be mistaken at first for an eruption cyst (a harmless bluish bubble over an emerging tooth), which can delay the diagnosis. When a pediatrician or dentist suspects a tumor, imaging comes next. A CT (computed tomography) scan, a detailed X-ray series, shows how far the tumor has expanded the bone and moved the teeth. An MRI (magnetic resonance imaging) scan shows the soft tissue and how close the tumor sits to the eye, nose and brain, which helps plan surgery. The diagnosis is confirmed by examining tumor tissue under a microscope, either from a biopsy or after the tumor is removed. MNTI has a distinctive mix of two cell types, which pathologists confirm with special stains. This step matters because several childhood cancers, such as neuroblastoma and Ewing sarcoma, can look similar on scans. Doctors may also test the urine for a substance called vanillylmandelic acid (VMA), which some of these tumors release. A raised level supports the diagnosis, but most children with MNTI have normal levels, so a normal result does not rule it out.
Surgery to remove the whole tumor is the main treatment, and it cures most children. An international expert consensus published in 2026 puts the cure rate with surgery at roughly 80 to 90 percent. The surgical team tries to take the tumor out completely while protecting the growing jaw, teeth, eye and other nearby structures. For a small, well-contained tumor this may be a relatively limited operation. A larger tumor may require removing part of the jaw, which lowers the chance of the tumor coming back but can leave lasting effects on appearance, teeth and growth, so later reconstruction may be needed. Chemotherapy (medicines that kill fast-dividing cells) is reserved for harder situations: a tumor that cannot be removed safely, one that keeps coming back after surgery, or one that has spread. In some infants it is given first to shrink a large tumor so surgery can remove it with less damage. Radiation therapy is generally avoided because of its long-term effects on a baby's developing face and brain. Because MNTI is rare, care works best with a team experienced in childhood tumors, including head and neck or craniofacial surgeons, pediatric oncologists and pathologists.
Most children recover well after the tumor is fully removed and go on to grow and develop normally. The main concern in the following months is recurrence, meaning the tumor grows back. Published case reviews suggest this happens in roughly 10 to 25 percent of children, usually within the first few months after surgery and less often after the first year. Babies diagnosed in their first two months and tumors that could not be completely removed carry a higher chance of returning. A recurrence is usually treated with further surgery, and many children are still cured. Follow-up is closest early on, with frequent examinations and imaging in the first months, then spacing out over the next couple of years. Children who had part of the jaw removed may need ongoing dental, orthodontic and reconstructive care as their face grows, and some may need feeding or speech support. Tumors in the skull or brain, and the rare malignant forms, follow a more variable course and need longer, specialist-led follow-up.
Have a pediatrician or pediatric dentist examine any lump or swelling of a baby's gum, jaw or face that grows over days to weeks, particularly one that looks bluish or black. Early assessment matters because a smaller tumor is easier to remove completely. After treatment, contact the care team promptly about new swelling at or near the operation site, a lump in the neck, difficulty feeding, or nosebleeds. For a tumor in the skull, also report new vomiting, unusual sleepiness, a bulging soft spot or loss of skills, which can mean rising pressure inside the head.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Melanotic Neuroectodermal Tumor is like, what's helped you, or ask the community a question.